or Try an Advanced Search...

    Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    C 46.33 2.94% 1.33
    CRBP closed down 2.0 percent on Friday, May 17, 2024, on 47 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical CRBP trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 2.94%
    Overbought Stochastic Strength 2.94%
    Wide Bands Range Expansion 0.88%
    Overbought Stochastic Strength 0.88%
    Up 3 Days in a Row Strength 0.88%
    Shooting Star Candlestick Bearish 4.95%
    Pocket Pivot Bullish Swing Setup 4.95%
    Wide Bands Range Expansion 4.95%
    Overbought Stochastic Strength 4.95%
    Upper Bollinger Band Touch Strength 4.95%
    Older End-of-Day Signals for CRBP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout 27 minutes ago
    Rose Above Previous Day's High about 1 hour ago
    Up 3% about 1 hour ago
    Up 2% about 1 hour ago
    Up 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CRBP Chart by TradingView
    Basic chart:

    Profile

    Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Organ Systems Hearing Cystic Fibrosis Hearing Aid Fibrotic Disease Treatment Of Cystic Fibrosis Ajulemic Acid Channelopathies Scleroderma

    Is CRBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Corbus Pharmaceuticals a new outperform at RBC on cancer, obesity assets
    May 9 Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
    May 8 Cannabis Stock Movers For May 8, 2024
    May 7 Corbus Pharmaceuticals EPS of -$0.83 beats by $0.26
    May 7 Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
    May 1 Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum
    Apr 24 Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
    Apr 19 Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology
    Apr 19 These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
    Apr 16 Cannabis Stock Gainers And Losers From April 16, 2024
    See more CRBP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 49.8699
    52 Week Low 3.0334
    Average Volume 266,278
    200-Day Moving Average 17.49
    50-Day Moving Average 39.75
    20-Day Moving Average 39.71
    10-Day Moving Average 42.86
    Average True Range 2.87
    RSI (14) 64.79
    ADX 22.81
    +DI 27.94
    -DI 13.60
    Chandelier Exit (Long, 3 ATRs) 37.69
    Chandelier Exit (Short, 3 ATRs) 40.64
    Upper Bollinger Bands 47.04
    Lower Bollinger Band 32.39
    Percent B (%b) 0.86
    BandWidth 36.90
    MACD Line 1.97
    MACD Signal Line 1.35
    MACD Histogram 0.6249
    Fundamentals Value
    Market Cap 465.16 Million
    Num Shares 10.3 Million
    EPS -11.12
    Price-to-Earnings (P/E) Ratio -4.05
    Price-to-Sales 163.32
    Price-to-Book 744.81
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 48.89
    Resistance 3 (R3) 48.86 47.54 48.24
    Resistance 2 (R2) 47.54 46.55 47.55 48.02
    Resistance 1 (R1) 46.27 45.94 45.61 46.30 47.81
    Pivot Point 44.95 44.95 44.62 44.96 44.95
    Support 1 (S1) 43.68 43.96 43.02 43.70 42.19
    Support 2 (S2) 42.36 43.35 42.37 41.98
    Support 3 (S3) 41.09 42.36 41.76
    Support 4 (S4) 41.11